Misdiagnosis of Hodgkin disease as histiocytosis is associated with adverse consequences

Affiliations

• ¹ Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France. [email protected].
• ² Pathology Department, Ambroise-Paré Hospital, 9 Avenue Charles de Gaulle, Boulogne, France. [email protected].
• ³ Hémato-Oncologie Pédiatrique, CHU de Reims, 51100, Reims, France.
• ⁴ Internal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, APHP, Pitié-Salpêtrière Hospital, Boulevard de L'hôpital, 75014, Paris, France. [email protected].
• ⁵ Rheumatology Department, CHU Hospital La Cavale-Blanche, Centre National de Référence Des Maladies Auto-Immunes Rares (CERAINO), LBAI, UMR1227, Brest, France.
• ⁶ Hématologie, CHU de Marseille, 147 Bd Baille, 13005, Marseille, France.
• ⁷ Pédiatrie, GH du Havre, Le Havre, France.
• ⁸ Médecine Interne, CHU de Montpellier, Hôpital Saint Eloi, Montpellier, France.
• ⁹ Hématologie Clinique, CHU Sud Réunion, St Pierre, France.
• ¹⁰ Internal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, APHP, Pitié-Salpêtrière Hospital, Boulevard de L'hôpital, 75014, Paris, France.
• ¹¹ Département de Médecine Interne, CHU Timone AP-HM, Aix-Marseille Université, Marseille, France.
• ¹² AP-HP, Armand-Trousseau Hospital, Service d'Hémato-Oncologie Pédiatrique, Centre de Référence Des Histiocytoses, Paris, France.